Methods for the treatment of muscular dystrophy associated with dysferlindeficiency

Details for Australian Patent Application No. 2007313170 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Spuler, Simone; Wenzel, Katrin; Rother, Russell P.

Agent Shelston IP

Pub. Number AU-A-2007313170

PCT Pub. Number WO2008/048689

Priority 60/853,213 20.10.06 US

Filing date 19 October 2007

Wipo publication date 24 April 2008

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/048689 Priority application(s): WO2008/048689

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007313180-Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto

2007313160-Drug-delivery endovascular stent and method of use